These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33122070)

  • 1. Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment.
    Mukhtar M; Pallagi E; Csóka I; Benke E; Farkas Á; Zeeshan M; Burián K; Kókai D; Ambrus R
    Int J Biol Macromol; 2020 Dec; 165(Pt B):3007-3019. PubMed ID: 33122070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis.
    Mukhtar M; Csaba N; Robla S; Varela-Calviño R; Nagy A; Burian K; Kókai D; Ambrus R
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide.
    Changsan N; Sinsuebpol C
    Pharm Dev Technol; 2021 Feb; 26(2):181-192. PubMed ID: 33213232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
    Kushwaha K; Dwivedi H
    Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
    Rawal T; Parmar R; Tyagi RK; Butani S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.
    Garg T; Rath G; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):997-1001. PubMed ID: 25682840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.
    Omar SM; Maziad NA; El-Tantawy NM
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):78-87. PubMed ID: 30526251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile one-step jet-milling approach for the preparation of proliposomal dry powder for inhalation as effective delivery system for anti-TB therapeutics.
    Srichana T; Eze FN; Thawithong E
    Drug Dev Ind Pharm; 2022 Oct; 48(10):528-538. PubMed ID: 36214588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin.
    Ambrus R; Csóka I; Fenyes E; Orosz L; Sarkadi ÁN; Burián K; Kókai D; Mukhtar M
    J Pharm Sci; 2024 Jul; 113(7):1946-1959. PubMed ID: 38643899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.
    Stagner WC; Iyer M; Rathod V; Meruva S; Staton S; Haware RV
    Int J Pharm; 2019 Dec; 572():118774. PubMed ID: 31678392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
    Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
    Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
    Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
    Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of dimple-shaped chitosan carrier for ethambutol dihydrochloride dry powder inhaler.
    Ahmad MI; Ungphaiboon S; Srichana T
    Drug Dev Ind Pharm; 2015 May; 41(5):791-800. PubMed ID: 24694185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
    Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
    Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need.
    Patil TS; Deshpande AS; Deshpande S; Shende P
    J Drug Target; 2019 Jan; 27(1):12-27. PubMed ID: 29561179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.